Nanjing Gaoke Company Limited

Equities

600064

CNE000000PX6

Real Estate Development & Operations

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-06 pm EDT			5-day change	1st Jan Change
6.37 ^CNY	+0.16%		-0.31%	+5.46%

Apr. 26	Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 26	Nanjing Gaoke's Q4 Contracted Sales Drop 69%	MT

Njing Hanxin Pharmaceutical Technology Co., Ltd. intends to acquire 51% stake in Nanjing Cuccess Pharmaceutical Co., Ltd. from Nanjing Gaoke Company Limited for approximately CNY 180 million.

September 08, 2021

Nanjing Hanxin Pharmaceutical Technology Co., Ltd. intends to acquire 51% stake in Nanjing Cuccess Pharmaceutical Co., Ltd. from Nanjing Gaoke Company Limited (SHSE:600064) on August 30, 2021. Nanjing Hanxin Pharmaceutical Technology Co., Ltd. signed contract to acquire 51% stake in Nanjing Cuccess Pharmaceutical Co., Ltd. from Nanjing Gaoke Company Limited for approximately CNY 180 million on September 7, 2021. As of now, Nanjing Hanxin Pharmaceutical Technology Co., Ltd. has paid CNY 55.03 million as deposit while remaining CNY 129.39 million payable in installments.

Latest news about Nanjing Gaoke Company Limited

Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Nanjing Gaoke's Q4 Contracted Sales Drop 69%	Jan. 26	MT
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Nanjing Gaoke Raises 500 Million Yuan From 180-Day Bond Sale	23-10-19	MT
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Nanjing Gaoke Issues Ultra-Short-Term Bonds of 900 Million Yuan	23-07-06	MT
Nanjing Gaoke Issues 350 Million Yuan Ultra-Short-Term Bonds	23-05-26	MT
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Nanjing Gaoke Company Limited(XSSC:600064) added to S&P Global BMI Index	22-09-19	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-17	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-19	CI
Nanjing TianYiHeXin Electronics Co.,Ltd. announced that it has received $31.4 million in funding from a group of investors	22-02-20	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Nanjing Cyber Peace Tech Co., Ltd announced that it has received $31 million in funding from Nanjing Gaoke Company Limited, Nanjing Dongpingheng Investment Management Co., Ltd., Jiangsu Addor Equity Investment Fund Management Co., Ltd.	21-10-19	CI
Njing Hanxin Pharmaceutical Technology Co., Ltd. intends to acquire 51% stake in Nanjing Cuccess Pharmaceutical Co., Ltd. from Nanjing Gaoke Company Limited for approximately CNY 180 million.	21-09-08	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-19	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-30	CI
Nanjing Gaoke Company Limited Announces Cash Dividend for 2019, Payable on July 7, 2020	20-06-27	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-29	CI
Nanjing Gaoke Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-29	CI
Nanjing Gaoke Company Limited Provides Guidance Fro 2019	20-01-20	CI

Chart Nanjing Gaoke Company Limited

Duration

Period

More charts

Company Profile

NANJING GAOKE COMPANY LIMITED is a China-based company, principally engaged in real estate and municipal businesses, medical health business and equity investment business. Its real estate business includes residential development, commercial operations and property management, among others. Its medical health business includes the research and development, manufacture and sales of pharmaceuticals. The Company operates its businesses primarily in Nanjing, Jiangsu province, China.

Sector

Real Estate Development & Operations

Calendar

2024-05-23 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Residential Real Estate Development

	1st Jan change	Capi.
NANJING GAOKE COMPANY LIMITED	+5.46%	1.53B
VONOVIA SE	+0.46%	24.75B
CHINA VANKE CO., LTD.	-28.11%	11.34B
AKELIUS RESIDENTIAL PROPERTY AB	+8.76%	10.89B
DEUTSCHE WOHNEN SE	-23.14%	7.7B
VINHOMES	-4.98%	7.06B
LEG IMMOBILIEN SE	+6.00%	6.66B
VINGROUP	+0.90%	6.56B
OPEN HOUSE GROUP CO., LTD.	+16.50%	3.71B
IIDA GROUP HOLDINGS CO., LTD.	-4.33%	3.68B

Residential Real Estate Development